SANJIVIN.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
SANJIVIN.BOSanjivani Paranteral Limited.	$180.00	+1.52%	$2.2B	—
AMBALALSA.BOAmbalal Sarabhai Enterprises Limited	$39.36	+1.89%	$3.0B	—
BDH.BOBDH Industries Limited	$500.00	-1.01%	$2.9B	—
NATCAPSUQ.BONatural Capsules Limited	$172.75	-4.72%	$1.8B	—
NURECA.BONureca Limited	$334.50	+2.61%	$3.3B	—
NURECA.NSNureca Limited	$338.30	+5.00%	$3.4B	—
OXYGENTAPH.BOOxygenta Pharmaceutical Ltd.	$52.76	-1.27%	$2.0B	—

Source: Financial Modeling Prep · peers by sector/industry

Sanjivani Paranteral Limited.

Sanjivani Paranteral Ltd. is a pharmaceutical company that manufactures and supplies a variety of medical products. Its offerings include medications such as antibiotics, anti-emetics, anti-diabetics, and anti-fungals. The firm was established on October 5, 1994, by Anami H. Khemka, Ashwin A. Khemka, and Somesh Khemka, and its central operations are based in Mumbai, India.

www.sanjivani.co.in

Employees: 43
IPO / List date: Mar 22, 2002
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds SANJIVIN.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in SANJIVIN.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded SANJIVIN.BO yet.